Stock Fundamentals

Company Information

Company Name
Si-Bone Inc
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US8257041090
CIK: 0001459839
CUSIP: 825704109
Currency: USD
Full Time Employees: 376
Phone: 408 207 0700
Fiscal Year End: December
IPO Date: Oct 17, 2018
Description:

SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Address:

471 El Camino Real, Santa Clara, CA, United States, 95050

Directors & Officers

Name Title Year Born
Mr. Jeffrey W. Dunn Executive Chairman 1956
Ms. Laura A. Francis MBA CEO & Director 1967
Mr. Anshul Maheshwari COO & CFO 1980
Mr. Michael A. Pisetsky J.D. Chief Business & Legal Affairs Officer, Secretary and General Counsel 1978
Mr. Anthony J. Recupero Advisor 1960
Dr. Scott A. Yerby Ph.D. Senior VP of Engineering & CTO 1968
Mr. Saqib Iqbal Vice President of Financial Planning & Analysis and Investor Relations NA
Mr. Ian Bailey Vice President of Product & Marketing NA
Dr. Daniel Joseph Cher M.D. Senior Vice President of Clinical, Regulatory Affairs & Quality 1965
Dr. W. Carlton Reckling M.D. Chief Medical Officer & VP of Medical Affairs 1963

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 02, 2026 Anshul Maheshwari N/A Sale 3.32K $12.87 $42.70K
Apr 02, 2026 Michael A Pisetsky N/A Sale 1.34K $12.86 $17.17K
Apr 01, 2026 Michael A Pisetsky N/A Sale 1.80K $12.95 $23.30K
Mar 12, 2026 Mika Nishimura N/A Sale 4.10K $13.83 $56.70K
Feb 17, 2026 Anshul Maheshwari N/A Sale 21.53K $15.37 $330.89K
Feb 17, 2026 Anthony J Recupero N/A Sale 21.05K $15.40 $324.15K
Feb 17, 2026 Laura Francis N/A Sale 93.48K $15.32 $1.43M
Feb 17, 2026 Michael A Pisetsky N/A Sale 20.76K $15.35 $318.60K
Feb 02, 2026 Jeffrey W Dunn N/A Sale 337.00 $16.42 $5.53K
Jan 08, 2026 Jeffrey W Dunn N/A Sale 20.00K $21.28 $425.60K
Jan 02, 2026 Anshul Maheshwari N/A Sale 5.23K $19.64 $102.70K
Jan 02, 2026 Michael A Pisetsky N/A Sale 3.46K $19.62 $67.89K
Jan 02, 2026 Anthony J Recupero N/A Sale 3.68K $19.62 $72.14K
Dec 18, 2025 Michael A Pisetsky N/A Sale 19.60K $20.15 $394.94K
Dec 18, 2025 Anshul Maheshwari N/A Sale 18.54K $20.15 $373.62K
Dec 08, 2025 Jeffrey W Dunn N/A Sale 1.24K $19.33 $23.99K
Dec 08, 2025 Jeffrey W Dunn N/A Sale 18.76K $19.33 $362.61K
Nov 25, 2025 Anshul Maheshwari N/A Sale 100.00 $20.00 $2.00K
Nov 24, 2025 Michael A Pisetsky N/A Sale 400.00 $20.00 $8.00K
Nov 21, 2025 Anshul Maheshwari N/A Sale 1.20K $20.01 $24.01K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
First Light Asset Management, LLC 5.35M Mar 31, 2026 12.07% $6.06 6.36%
BlackRock Inc 3.43M Mar 31, 2026 7.73% $0.00 -1.69%
American Century Companies Inc 2.51M Mar 31, 2026 5.66% $0.02 9.07%
Vanguard Group Inc 2.50M Dec 31, 2025 5.64% $0.00 0.46%
Brown Advisory Holdings Inc 2.12M Mar 31, 2026 4.79% $0.04 -13.79%
Cadian Capital Management LP 1.89M Mar 31, 2026 4.26% $2.90 61.17%
Vanguard Capital Management, LLC 1.76M Mar 31, 2026 3.98% $0.00 0.00%
Granahan Investment Management Inc.. 1.74M Mar 31, 2026 3.92% $1.06 97.59%
Impax Asset Management Group PLC 1.43M Mar 31, 2026 3.21% $0.13 18.75%
Nuveen, LLC 1.29M Mar 31, 2026 2.90% $0.00 -9.59%
Silvercrest Asset Management Group LLC 1.24M Mar 31, 2026 2.81% $0.11 -10.00%
State Street Corp 1.13M Mar 31, 2026 2.55% $0.00 12.39%
Paradigm Capital Management, Inc. 1.13M Mar 31, 2026 2.54% $0.54 113.27%
Gilder Gagnon Howe & CO LLC 1.05M Mar 31, 2026 2.36% $0.16 153.29%
Geode Capital Management, LLC 951.73K Mar 31, 2026 2.15% $0.00 3.27%
Champlain Investment Partners, LLC 877.61K Mar 31, 2026 1.98% $0.14 -21.37%
Point72 Asset Management, L.P. 840.35K Mar 31, 2026 1.89% $0.01 12.65%
Wellington Management Company LLP 772.61K Mar 31, 2026 1.74% $0.00 -6.06%
Morgan Stanley - Brokerage Accounts 712.51K Mar 31, 2026 1.61% $0.00 247.74%
Arnhold & S. Bleichroeder Advisers, LLC 638.94K Mar 31, 2026 1.44% $0.01 18.88%

Shares Statistics

Shares Outstanding: 44.35M
Shares Float: 42.78M
% Insiders: 339.20%
% Institutions: 10,808.20%
Short % Float: 15.48%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 American Century U.S. Small Cap Growth 1.90M 4.29% ▲ 6.54% Mar 31, 2026
2 American Century Small Cap Growth Inv 1.90M 4.29% ▲ 6.54% Mar 31, 2026
3 Impax Small Cap Institutional 1.43M 3.22% ▲ 0.00% Apr 30, 2026
4 Impax US Small Cap Strategy Composite 1.43M 3.22% ▲ 0.00% Mar 31, 2026
5 Vanguard Total Stock Mkt Idx Inv 1.29M 2.91% ▲ 0.00% Apr 30, 2026
6 iShares Russell 2000 ETF 913.92K 2.07% ▲ 0.93% May 29, 2026
7 Champlain Small Company Fund, LLC 831.16K 1.88% ▼ 2.67% May 31, 2026
8 CREF Total Global Stock Account R3 768.14K 1.74% ▼ 2.55% Apr 30, 2026
9 First Eagle Small Cap Opportunity I 645.90K 1.46% ▲ 3.65% May 31, 2026
10 First Eagle US Small Cap Strategy 556.23K 1.26% ▲ 18.03% Mar 31, 2026

Valuation Metrics

Enterprise Value: $582.13M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $683.87M
EBITDA: $-13.83M
Book Value: $4.05
Earnings/Share: $-0.39
Profit Margin: -8.10%
Operating Margin: -9.69%
ROA (TTM): -5.30%
ROE (TTM): -9.65%
Revenue (TTM): $206.22M
Revenue/Share (TTM): $4.76
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 11.20%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 8.55x 0.21x 0.26x -4.23x -3.35x
2024-12-31 7.66x 0.22x 0.28x -10.25x -1.59x
2023-12-31 9.01x 0.22x 0.26x -13.56x -1.09x
2022-12-31 6.50x 0.37x 0.38x -21.15x -0.66x
2021-12-31 10.41x 0.27x 0.29x -9.63x -0.71x
2020-12-31 16.20x 0.23x 0.24x -6.32x -1.08x
2019-12-31 5.94x 0.62x 0.46x -7.27x -1.20x
2018-12-31 15.11x 0.43x 0.35x -2.18x -3.47x
2017-12-31 4.46x -0.60x 4.61x -2.80x -4.89x
2016-12-31 2.71x -0.27x 3.76x -5.31x -1.80x
2015-12-31 4.39x 15.80x 0.91x N/A -1.99x
2014-12-31 3.74x 4.40x 0.76x N/A -1.16x
2013-12-31 1.61x -1.34x 1.09x N/A -0.42x
2012-12-31 N/A N/A N/A N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about SIBN.US!